Here we report the activity of liposomes comprising egg phosphatidylcholine (PC) and stearylamine (SA) against Leishmania donovani parasites. Both promastigotes and intracellular amastigotes in vitro and in vivo were susceptible to SA-PC liposomes. A single dose of 55 mg of SA-PC liposomes/animal could significantly reduce the hepatic parasite burden by 85 and 68% against recent and established experimental visceral leishmaniasis, respectively, suggesting their strong therapeutic potential
Background: Resistance of Leishmania donovani to pentavalent antimonials, the first-line treatment o...
Leishmaniasis is a parasitic neglected tropical disease and result in a broad spectrum of clinical m...
Visceral leishmaniasis (VL) is a chronic debilitating disease endemic in tropical and subtropical ar...
Here we report the activity of liposomes comprising egg phosphatidylcholine (PC) and stearylamine (S...
Liposomes consisting of stearylamine (SA) and egg yolk phosphatidylcholine (PC) were studied for the...
Objectives: Lipid-associated formulations of antileishmanial agents have proved to be more effective...
Objectives: Lipid-associated formulations of antileishmanial agents have proved to be more effective...
AbstractLeishmaniasis is a parasitic disease caused by the intramacrophage protozoa Leishmania spp. ...
Background: Resistance of Leishmania donovani to pentavalent antimonials, the first-line treatment o...
The efficacy of sodium stibogluconate against Leishmania donovani infections was markedly enhanced b...
AbstractThe efficacy of sodium stibogluconate against Leishmania donovani infections was markedly en...
Leishmaniasis is a parasitic disease caused by the intramacrophage protozoa Leishmania spp. and may ...
Abstract: INTRODUCTION: Leishmaniasis is a disease caused by the protozoan Leishmania that resides...
Pentavalent antimonials have been the first-line treatment for leishmaniasis for decades. However, t...
Background: Resistance of Leishmania donovani to pentavalent antimonials, the first-line treatment o...
Leishmaniasis is a parasitic neglected tropical disease and result in a broad spectrum of clinical m...
Visceral leishmaniasis (VL) is a chronic debilitating disease endemic in tropical and subtropical ar...
Here we report the activity of liposomes comprising egg phosphatidylcholine (PC) and stearylamine (S...
Liposomes consisting of stearylamine (SA) and egg yolk phosphatidylcholine (PC) were studied for the...
Objectives: Lipid-associated formulations of antileishmanial agents have proved to be more effective...
Objectives: Lipid-associated formulations of antileishmanial agents have proved to be more effective...
AbstractLeishmaniasis is a parasitic disease caused by the intramacrophage protozoa Leishmania spp. ...
Background: Resistance of Leishmania donovani to pentavalent antimonials, the first-line treatment o...
The efficacy of sodium stibogluconate against Leishmania donovani infections was markedly enhanced b...
AbstractThe efficacy of sodium stibogluconate against Leishmania donovani infections was markedly en...
Leishmaniasis is a parasitic disease caused by the intramacrophage protozoa Leishmania spp. and may ...
Abstract: INTRODUCTION: Leishmaniasis is a disease caused by the protozoan Leishmania that resides...
Pentavalent antimonials have been the first-line treatment for leishmaniasis for decades. However, t...
Background: Resistance of Leishmania donovani to pentavalent antimonials, the first-line treatment o...
Leishmaniasis is a parasitic neglected tropical disease and result in a broad spectrum of clinical m...
Visceral leishmaniasis (VL) is a chronic debilitating disease endemic in tropical and subtropical ar...